April's been a month of biotech bloodbaths. In a 15-day span, Incyte Corporation (NASDAQ: INCY), Prothena Corporation PLC (NASDAQ: PRTA), and Celldex Therapeutics Inc. (NASDAQ: CLDX)have all reported clinical trial failures that have hammered their stock prices.
Lessons to Learn From April's Biotech Blowups
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться